| Name | Title | Contact Details |
|---|---|---|
Edmund Siy |
Chief Information Officer | Profile |
Compassion-First Pet Hospitals is a family of specialty and emergency veterinary hospitals located throughout the United States. We recruit experienced doctors across a wide range of specialties, including minimally-invasive surgery and integrative oncology, and we invest in novel technologies rarely found in veterinary medicine, such as lithotripsy for kidney or bladder stones. We believe in the importance of having a strong regional presence, which enables our veterinarians to seamlessly collaborate with one another and provides easy access to medical advancements and multidisciplinary expertise. We are Compassion-First because we put compassion first. It guides everything we do. We are committed to treating each family with kindness and sensitivity as we lead them through the best options for their pet`s comfort and quality of life. We foster a culture of respect, communication and cooperation among colleagues and staff, and in our daily interactions with the rDVM community. Most importantly, we know that the key to excellent patient outcomes is found through collaboration that is rooted in compassion. We are committed to these principles and are changing the veterinary landscape with our unique approach.
The mission of Life Line Screening is to make people aware of an undetected health problem and encourage them to seek follow up care with their physician. We are dedicated to providing the highest quality preventive screenings at an affordable rate.
Agennix is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Houston, TX. To find more information about Agennix, please visit www.agennix.com
Signature is a Virginia-based multi-family office, offering clients comprehensive strategies and solutions for all aspects of their financial life. With assets under management in excess of $3.7 billion, Signature takes an intelligent approach to creating customized plans for their high net worth individuals and families.
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company`s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.